BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 3902971)

  • 1. A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material.
    Watson JV; Sikora K; Evan GI
    J Immunol Methods; 1985 Oct; 83(1):179-92. PubMed ID: 3902971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
    Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
    Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.
    Curling M; Stenning S; Hudson CN; Watson JV
    J Clin Pathol; 1998 Jun; 51(6):455-61. PubMed ID: 9771445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer.
    Watson JV; Stewart J; Evan GI; Ritson A; Sikora K
    Br J Cancer; 1986 Mar; 53(3):331-7. PubMed ID: 3964537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical brush biopsy specimens suitable for DNA and oncoprotein analysis using flow cytometry.
    Elias-Jones J; Hendy-Ibbs P; Cox H; Evan GI; Watson JV
    J Clin Pathol; 1986 May; 39(5):577-81. PubMed ID: 3722410
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.
    Hendy-Ibbs P; Cox H; Evan GI; Watson JV
    Br J Cancer; 1987 Mar; 55(3):275-82. PubMed ID: 3552016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.
    Jones DJ; Ghosh AK; Moore M; Schofield PF
    Br J Cancer; 1987 Dec; 56(6):779-83. PubMed ID: 3325094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes and cancer: a clinical perspective.
    Ellis M; Sikora K
    J R Coll Physicians Lond; 1987 Apr; 21(2):122-8. PubMed ID: 3295213
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncogenes and gastrointestinal cancer.
    Forgacs I
    Gut; 1988 Apr; 29(4):417-21. PubMed ID: 3286381
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenotypic characteristics of three human non-Hodgkin lymphoma lines: flow cytometric analysis after long-term maintenance.
    Kopper L; Bánkfalvi A; Mihalik R; Páloczi K; Benczur M; Lapis K
    Clin Exp Immunol; 1988 Nov; 74(2):295-9. PubMed ID: 3224446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc oncoprotein levels in bladder cancer.
    Masters JR; Vesey SG; Munn CF; Evan GI; Watson JV
    Urol Res; 1988; 16(5):341-4. PubMed ID: 3059654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.
    Sundaresan V; Forgacs IC; Wight DG; Wilson B; Evan GI; Watson JV
    J Clin Pathol; 1987 Nov; 40(11):1274-81. PubMed ID: 2826545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-myc oncogene product expression and prognosis in operable breast cancer.
    Locker AP; Dowle CS; Ellis IO; Elston CW; Blamey RW; Sikora K; Evan G; Robins RA
    Br J Cancer; 1989 Nov; 60(5):669-72. PubMed ID: 2679850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of c-myc related to the proliferation and transformation of rat liver-derived epithelial cells.
    Sinha S; Neal GE; Legg RF; Watson JV; Pearson C
    Br J Cancer; 1989 May; 59(5):674-6. PubMed ID: 2660895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillomavirus and c-myc antigen expression in normal and neoplastic cervical epithelium.
    Hughes RG; Neill WA; Norval M
    J Clin Pathol; 1989 Jan; 42(1):46-51. PubMed ID: 2537854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of Hoechst 33342 uptake as an indicator of multi-drug resistance in human lung cancer.
    Morgan SA; Watson JV; Twentyman PR; Smith PJ
    Br J Cancer; 1989 Sep; 60(3):282-7. PubMed ID: 2477051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced nuclear binding of a DNA minor groove ligand (Hoechst 33342) and its impact on cytotoxicity in drug resistant murine cell lines.
    Morgan SA; Watson JV; Twentyman PR; Smith PJ
    Br J Cancer; 1990 Dec; 62(6):959-65. PubMed ID: 2257227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue preparation for simultaneous flow cytometric quantitation of tumour associated antigens and DNA in solid tumours.
    van Dam PA; Watson JV; Lowe DG; Cox H; Curling M; Shepherd JH
    J Clin Pathol; 1990 Oct; 43(10):833-9. PubMed ID: 2229431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.
    Rowley S; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP
    World J Surg; 1990; 14(4):545-50; discussion 551. PubMed ID: 2200214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine overcomes a restriction point associated with DNA replication, but does not accelerate mitosis.
    Downes CS; Musk SR; Watson JV; Johnson RT
    J Cell Biol; 1990 Jun; 110(6):1855-9. PubMed ID: 2161852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.